Inactive Instrument

Vringo, Inc. Share Price Nasdaq

Equities

US92911N1046

Personal Services

End-of-day quote Nasdaq
- USD - Intraday chart for Vringo, Inc.
Sales 2022 55.94M 4.46B Sales 2023 30.11M 2.4B Capitalization 7.27M 580M
Net income 2022 -32M -2.55B Net income 2023 -27M -2.15B EV / Sales 2022 0.04 x
Net cash position 2022 28.08M 2.24B Net cash position 2023 11.96M 953M EV / Sales 2023 -0.16 x
P/E ratio 2022
-1.04 x
P/E ratio 2023
-0.26 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 98.07%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 59 14/07/19
Director of Finance/CFO 54 09/07/23
Corporate Officer/Principal - 31/12/21
Members of the board TitleAgeSince
Chief Executive Officer 59 14/07/19
Director/Board Member 64 02/02/20
Chairman 60 07/02/16
More insiders
XWELL, Inc. is a global health and wellness holding company. The Company operates through four segments: XpresTest, XpresSpa, Treat, and Naples Wax Center. The XpresTest segment provides diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the centers for disease control and prevention (CDC’s) bio-surveillance program. XpresTest’s HyperPointe business provides a range of service and support options for its customers, including technical support services and advanced services. The XpresSpa segment provides travelers premium spa services, including massage, nail and skin care, as well as spa and travel products. Treat segment is a wellness brand that provides access to wellness services for travelers at on-site centers. Naples Wax Center segment operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products.
More about the company